terapia de combinação de um anticorpo anti-cd20 tipo ii com um agente ativo anti-bcl-2

The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.

Bibliographische Detailangaben

Hauptverfasser:	CHRISTIAN KLEIN, PAMELA BRAEMER, THOMAS FRIESS, PABLO UMANA
Format:	Patent
Sprache:	por
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!